Shopping Cart
- Remove All
- Your shopping cart is currently empty
PMEDAP is a potent inhibitor of Moloney murine sarcoma virus (MSV)-induced tumor formation and mortality, as well as a human immunodeficiency virus (HIV) replication inhibitor with anti-murine cytomegalovirus (MCMV) activity.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $29 | In Stock | |
2 mg | $42 | In Stock | |
5 mg | $68 | In Stock | |
10 mg | $107 | In Stock | |
25 mg | $238 | In Stock | |
50 mg | $381 | In Stock | |
100 mg | $573 | In Stock | |
200 mg | $779 | In Stock |
Description | PMEDAP is a potent inhibitor of Moloney murine sarcoma virus (MSV)-induced tumor formation and mortality, as well as a human immunodeficiency virus (HIV) replication inhibitor with anti-murine cytomegalovirus (MCMV) activity. |
In vivo | In Three-week-old male NMRI mice inoculated with MSV, PMEDAP (0.25-5 mg/kg; IP; daily;) effected a significant delay in tumor appearance and an enhancement of the survival rate of tumor-bearing mice. PMEDAP also suppressed tumor formation and mortality in a dose-dependent manner[2]. |
Molecular Weight | 288.2 |
Formula | C8H13N6O4P |
Cas No. | 113852-41-8 |
Smiles | C(COCP(=O)(O)O)N1C=2C(N=C1)=C(N)N=C(N)N2 |
Relative Density. | 2.03 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | 0.1 M NaOH: 14.29 mg/mL (49.58 mM), when pH is adjusted to 12 with NaOH. Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
0.1 M NaOH
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.